On March 2, 2022 Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet need, reported the company will release its fourth quarter and full year 2021 financial results and provide a business update on Wednesday, March 9, 2022 (Press release, Chemomab, MAR 2, 2022, View Source [SID1234609361]). The company will host a conference call and webcast at 8:00 a.m. Eastern Time on the same day, which will be broadcast live at the link below and on the company’s investor relations website at investors.chemomab.com/events. The conference call will also be available by telephone.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

During the conference call, Chemomab’s management team will review fourth quarter and full year 2021 performance, discuss recent and upcoming events and conduct a question-and-answer session.

Conference Call and Webcast Information:

Live Webcast at 8:00 am Eastern Time, March 9, 2022

Click this Webcast link to access the live webcast or replay.

The live webcast and replay can also be accessed at the News & Events section of the Investors page on the Chemomab website at investors.chemomab.com/events.

Please call 5-10 minutes before the scheduled start time and ask for the Chemomab conference call.

On March 2, 2022 Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, reported that Pascal Touchon, President and Chief Executive Officer, will participate in a panel discussion focused on cell therapy at the Cowen 42nd Annual Virtual Healthcare Conference on Wednesday, March 9, 2022, at 9:10 a.m. EST (Press release, Atara Biotherapeutics, MAR 2, 2022, View Source [SID1234609360]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the panel will be available by visiting the Investor Events and Presentations section of atarabio.com. An archived replay of the webcast will be available on the Company’s website for 30 days following the live presentation.

On March 2, 2022 Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, reported that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat as part of the Cowen 42nd Annual Health Care Conference on Wednesday, March 9, 2022, at 1:30 p.m. ET (Press release, Supernus, MAR 2, 2022, View Source [SID1234609359]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the presentation can be accessed by visiting Events & Presentations in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay will be available for 60 days on the Company’s website following the conference.

On March 2, 2022 Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, reported that management will participate in fireside chats at two upcoming virtual conferences (Press release, Protara Therapeutics, MAR 2, 2022, View Source [SID1234609358]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Cowen 42nd Annual Health Care Conference on March 9, 2022 at 9:10am ET
Oppenheimer 32nd Annual Healthcare Conference on March 15, 2022 at 2:00pm ET
A live webcast of the fireside chats can be accessed by visiting the Events and Presentations section of the Company’s website: View Source The webcasts will be archived on the Company’s website for 90 days following the presentations.

On March 2, 2022 SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, reported its participation in three in-person medical conferences and one virtual investor panel in March (Press release, Scynexis, MAR 2, 2022, View Source [SID1234609356]). Marco Taglietti, M.D., President and Chief Executive Officer of SCYNEXIS, will participate in a live panel discussion on drug development in Women’s Health. Event details can be found below:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conferences:

International Society for the Study of Women’s Sexual Health (ISSWSH)
Date: March 3-6, 2022
Location: Dallas
Event Page
Council on Resident Education in Obstetrics and Gynecology (CREOG) & Association of Professors of Gynecology and Obstetrics (APGO) Annual Meeting
Date: March 9-12, 2022
Location: Orlando
Event Page
Academy of Managed Care Pharmacy (AMCP)
Date: March 29- April 1, 2022
Location: Chicago
Event Page
Virtual Investor Panel:

Maxim Group’s Annual Growth Conference
Panel: Women’s Health Virtual Event
Date: March 28, 2022
Location: Virtual
Time: 3:00 p.m. ET
Event Page